| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/11/2008 | WO2008125951A3 Integrated oil condition and level sensor |
| 12/11/2008 | WO2008125420A3 Compounds for diagnosing apoptosis |
| 12/11/2008 | WO2008124109A3 System for pulling out regulatory elements using yeast |
| 12/11/2008 | WO2008122441A9 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
| 12/11/2008 | WO2008118969A3 Methods and agents for evaluating inflammatory bowel disease, and targets for treatment |
| 12/11/2008 | WO2008118369A3 Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity |
| 12/11/2008 | WO2008117195A3 Use of microcarrier beads for detection and/or isolation of cells by flow cytometry |
| 12/11/2008 | WO2008115948A3 Positive selection procedure for optically directed selection of cells |
| 12/11/2008 | WO2008115580A3 Method for detecting nitrofuran |
| 12/11/2008 | WO2008113328A3 Measuring device and method for optically determining the concentration of blood sugar and/or lactate in biological systems |
| 12/11/2008 | WO2008112990A3 Methods of diagnosis and treatment of crohn's disease |
| 12/11/2008 | WO2008112754A3 Methods, computer-accessible medium, and systems for generating a genome wide haplotype sequence |
| 12/11/2008 | WO2008111063A3 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions |
| 12/11/2008 | WO2008109560A3 Amelioration of cellular stress response |
| 12/11/2008 | WO2008109147A3 Gstp1 as teratogenic allele for autism and assays and methods based thereon |
| 12/11/2008 | WO2008109110A3 System for regulating blood pressure |
| 12/11/2008 | WO2008106648A3 Immunoassays exhibiting a reduction in prozone phenomena |
| 12/11/2008 | WO2008106054A3 Metabolic markers of diabetic conditions and methods of use thereof |
| 12/11/2008 | WO2008105973A3 Gas sensor test system and methods related thereto |
| 12/11/2008 | WO2008104953A3 Methods and targets for identifying compounds for regulating rhinovirus infection |
| 12/11/2008 | WO2008103200A3 Apparatus and method for performing ligand binding assays on microarrays in multiwell plates |
| 12/11/2008 | WO2008100596A3 Biomarkers of neurodegenerative disease |
| 12/11/2008 | WO2008100355A3 Apparatus and methods for solids deposition and analysis |
| 12/11/2008 | WO2008097840A3 Methods and compositions relating to the regulation of muc1 by hsf1 and stat3 |
| 12/11/2008 | WO2008097596A3 Nrf2 screening assays and related methods and compositions |
| 12/11/2008 | WO2008097439A3 Anti-autoimmune antibodies for treatment of pemphigus |
| 12/11/2008 | WO2008095730A3 Method for identifying an active ingredient complex, which modifies an enzymatic property of a synaptosomal / synaptic site of action complex in the region of a synaptosomal / synaptic membrane, biosensor arrangement, device for amperometric and/or potentiometric pharmacological site of action and/or active ingredient testi |
| 12/11/2008 | WO2008091617A3 Method for detecting age related macular degeneration in a subject |
| 12/11/2008 | WO2008091364A3 Nanoparticles as tags for bioanalyte detection by nuclear magnetic resonance or electron spin resonance |
| 12/11/2008 | WO2008088837A3 Expression of hla proteins on non-human cells |
| 12/11/2008 | WO2008088747A3 Method of monitoring hiv infection |
| 12/11/2008 | WO2008087170A3 Genes associated with schizophrenia |
| 12/11/2008 | WO2008086322A3 Method for estimating melting temperature of a nucleic acid in buffers containing divalent ions |
| 12/11/2008 | WO2008086035A9 Split mutant hydrolase fusion reporter and uses thereof |
| 12/11/2008 | WO2008085777A9 A method for early detection of cancer |
| 12/11/2008 | WO2008084403A8 Method and apparatus for the identification of persons based on the analysis of volatile substances of said persons in the surrounding gas |
| 12/11/2008 | WO2008079185A3 Pesticide biomarker |
| 12/11/2008 | WO2008074029A3 Protein profile for osteoarthritis |
| 12/11/2008 | WO2008073629A3 Bifunctional predictors of cancer treatment sensitivity and resistance |
| 12/11/2008 | WO2008073607A3 A method for estimating error from a small number of expression samples |
| 12/11/2008 | WO2008070865A3 Materials and methods for efficient and accurate detection of analytes |
| 12/11/2008 | WO2008070241A3 A method to measure serum biomarkers for the diagnosis of liver fibrosis |
| 12/11/2008 | WO2008069975A3 Methods of using f-spondin as a biomarker for cartilage degenerative conditions |
| 12/11/2008 | WO2008069965A3 Novel genes and proteins that home to developing microvessels |
| 12/11/2008 | WO2008067551A3 Genetic analysis systems and methods |
| 12/11/2008 | WO2008066997A3 A method for quantitative measurement of cardiac biochemical markers |
| 12/11/2008 | WO2008066612A8 Methods and targets for indentifying materials for regulating hyper-proliferative skin conditions |
| 12/11/2008 | WO2008054534A3 Screening systems utilizing rtp801 |
| 12/11/2008 | WO2008054523A3 Nanostructures, methods of synthesizing thereof, and methods of use thereof |
| 12/11/2008 | WO2008054502A3 Diagnostic and therapeutic methods related to anthrax exposure |
| 12/11/2008 | WO2008054480A3 Enhanced biohazard detection system |
| 12/11/2008 | WO2008054471A3 Monolayer-protected gold clusters: improved synthesis and bioconjugation |
| 12/11/2008 | WO2008051985A3 Method for separation and identification of biomolecules using unconventional gel electrophoresis and detection of single nanoparticle probes |
| 12/11/2008 | WO2008048639A3 Genetic prediction of schizophrenia susceptibility |
| 12/11/2008 | WO2008048508A3 Prognostic biomarkers in patients with ovarian cancer |
| 12/11/2008 | WO2008048221A3 Nanostructures for polarized imaging and receptor/ligand quantization: breaking the diffraction limit for imaging |
| 12/11/2008 | WO2008036680B1 Reagent sets and gene signatures for non-genotoxic hepatocarcinogenicity |
| 12/11/2008 | WO2008033408A3 Methods for identifying compounds that modulate cell signaling and methods employing such compounds |
| 12/11/2008 | WO2008030892A3 Drug design for tubulin inhibitors, compositions, and methods of treatment thereof |
| 12/11/2008 | WO2008030887A3 Methods for designing parp inhibitors and uses thereof |
| 12/11/2008 | WO2008024827A3 Design and selection of genetic targets for sequence resolved organism detection and identification |
| 12/11/2008 | WO2008019201A3 Enhanced diagnostic multimarker serological profiling |
| 12/11/2008 | WO2008014420A3 Non-human animal models for b-cell non-hodgkin's lymphoma and uses thereof |
| 12/11/2008 | WO2008013983A3 Opsin stabilizing compounds and methods of use |
| 12/11/2008 | WO2008008858A3 Cellspot™ applications |
| 12/11/2008 | WO2008008819A3 Diagnosis and treatment of neurological inflammation |
| 12/11/2008 | WO2008008500A3 Methods for making cancer prognoses based on the subcellular localization of biomarkers |
| 12/11/2008 | WO2008008349A3 Methods of quantitatively assessing inflammation with biosensing nanoparticles |
| 12/11/2008 | WO2008005426A3 Computer-aided pathological diagnosis system |
| 12/11/2008 | WO2008002620A3 Cell model for alzheimer's disease pathology |
| 12/11/2008 | WO2007140308A3 Methods of screening for trpm4 modulators of insulin secretion |
| 12/11/2008 | WO2007139766A3 Systems and methods for analyzing nanoreporters |
| 12/11/2008 | WO2007137124A3 Devices and methods for fluorescent inspection and/or removal of material in a sample |
| 12/11/2008 | WO2007126882A3 Analysis of splice variant expression data |
| 12/11/2008 | WO2007124314A3 Use of organic cation transporters for cancer diagnosis and therapy |
| 12/11/2008 | WO2007123976A3 Antibody profiling for determination of patient responsiveness |
| 12/11/2008 | WO2007123906A3 Recombinant antigens for diagnosis and prevention of murine typhus |
| 12/11/2008 | WO2007123832A3 Selection of fuel to optimize the operating range and minimize exhaust emissions of an hcci engine |
| 12/11/2008 | WO2007112007A3 Immobilized proteins and methods and uses thereof |
| 12/11/2008 | WO2007111938A3 Inflammation-inhibitory serum factors and uses thereof |
| 12/11/2008 | WO2007100770A3 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 12/11/2008 | WO2007098184A3 Methods and compositions for analyte detection |
| 12/11/2008 | WO2007092471A3 Methods for inhibition of lymphangiogenesis and tumor metastasis |
| 12/11/2008 | WO2007082144A3 B7-h1 and survivin in cancer |
| 12/11/2008 | WO2007002586A3 Methods for genotype screening |
| 12/11/2008 | WO2006086739A8 Ribonucleic acid interferernce molecules and methods for generating precursor/mature sequences and determining target sites |
| 12/11/2008 | WO2006060743A3 Glucose-transport related genes, polypeptides, and methods of use thereof |
| 12/11/2008 | WO1999027105A9 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 12/11/2008 | US20080307546 Cyclin-dependent kinase inhibitors and uses thereof |
| 12/11/2008 | US20080307540 Disease resistant cucumber plants |
| 12/11/2008 | US20080307537 Compositions and Methods for the Identification, Assessment, Prevention, and Therapy of Neurological Diseases, Disorders and Conditions |
| 12/11/2008 | US20080307536 Voltage-Gated, Ph-Sensitive Anion Channel And Its Novel Splice Variant Involved In Taste Sensation |
| 12/11/2008 | US20080306980 Method for Predicting Treatment Classes Using Animal Behavior Informatics |
| 12/11/2008 | US20080306409 Animal model for hyperpigmentation |
| 12/11/2008 | US20080306368 System and methods for processing analyte sensor data |
| 12/11/2008 | US20080306346 Diagnostic tool detecting the degradation status of Von Willebrand Factor multimers |
| 12/11/2008 | US20080306114 Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Hyperglycemia and Related Disorders |
| 12/11/2008 | US20080306093 Modulation of chemosensory receptors and ligands associated therewith |
| 12/11/2008 | US20080306076 Modulation of chemosensory receptors and ligands associated therewith |
| 12/11/2008 | US20080306074 Compositions Comprising Addl Receptors, Related Compositions, and Related Methods |